Home 
General Physiology and Biophysics 2018 General Physiology and Biophysics Vol.37, No.2, p.223–231, 2018
General Physiology and Biophysics 2018 General Physiology and Biophysics Vol.37, No.2, p.223–231, 2018
Journal info
Aims and Scope |
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
General Physiology and Biophysics Vol.37, No.2, p.223–231, 2018 |
||
| Title: Selective inhibition of smooth muscle plasma membrane transport Са2+,Mg2+-АТРase by calixarene C-90 and its activation by IPT-35 compound | ||
| Author: Iuliia I. Mazur, Tetyana O. Veklich, Oleksandr A. Shkrabak, Nikolai A. Mohart, Anatoly M. Demchenko, Inna V. Gerashchenko, Roman V. Rodik, Vitaly I. Kalchenko, Sergiy O. Kosterin | ||
| Abstract: We investigated the influence of calixarene C-90 and IPT-35 on plasma membrane Ca2+-pumping АТРase (PMCA), intracellular calcium homeostasis and myometrium smooth muscle strain contractions. It has been shown that both effectors (100 µM) affect PMCA enzymatic activity: calixarene C-90 inhibits it by 75% and IPT-35 activates it by 40%. These compounds don’t affect the Mg2+-АТРase, Mg2+-independent Са2+-АТРase and Na+,K+-АТРase enzymatic activities. C-90 inhibition coefficient I0.5 magnitude was approximately 20 µM and the Hill coefficient nH was 0.55. For IPT-35 activation, constant А0.5 was 6.4 and nH was 0.7. Mathematical modeling demonstrated the implication of calixarene C-90 on unexcited myocytes, which allows for a precise change in cytoplasm Ca2+ concentration and an influence on basal muscle tonus. By the same method, we determined that IPT-35 has a little influence on Ca2+ concentration in unexcited myocytes. It was also shown that calixarene C-90 in vitro can increase velocity of oxytocin-initiated contractions, whereas IPT-35 can suppress this aforementioned parameter. These results are promising for the design of new pharmacological compounds as better regulators of uterine contractions. Calixarene C-90 can be used in obstetric cases for the simultaneous use of oxytocin for enhancing uterine contractions, and IPT-35 for its antispasmodic effect on uterine tone. |
||
| Keywords: PMCA — Smooth muscle cell — Calixarene — Cyclopenta[d]pirimidine derivative | ||
| Published online: 27-Mar-2018 | ||
| Year: 2018, Volume: 37, Issue: 2 | Page From: 223, Page To: 231 | |
| doi:10.4149/gpb_2017035 |
||
|
|
 download file |
|